Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07101666 · ClinicalTrials.gov registry record · Phase 2
Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer
A Phase 2 study, sponsored by Washington University School of Medicine.
- Not yet
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT07101666 is a Phase 2 study that has not yet begun recruiting, run by Washington University School of Medicine. The registered enrollment target is 20 participants.
The verdict
NCT07101666, a Phase 2 study, has not yet begun recruiting, sponsored by Washington University School of Medicine.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
Standard treatment for patients with early stage gastric cancer consists of perioperative chemotherapy and surgical resection. If radiation therapy is administered in the adjuvant setting, the radiated area is often large and associated with significant toxicity. In this study, the investigators propose the addition of short course radiation therapy (SCRT) to chemotherapy in the neoadjuvant setting. The investigators hypothesize that this regimen of Total Neoadjuvant Therapy (TNT) will result in a higher rate of complete response (both pathologic and clinical), with less toxicity.
Interventions
- RADIATION Short course radiation therapy
- DRUG Standard of care neoadjuvant chemotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06-30 |
| Est. Completion | 2030-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07101666
The ClinicalTrials.gov registry entry for NCT07101666 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Short course radiation therapy is the first listed.
NCT07101666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07101666 about?
NCT07101666 is a clinical study titled "Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer". Standard treatment for patients with early stage gastric cancer consists of perioperative chemotherapy and surgical resection. If radiation therapy is administered in the adjuvant setting, the radiated area is often large and associated with significant toxicity. In this study, the investigators pr...
What is the current status of trial NCT07101666?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2026-06-30. Estimated completion is 2030-12-31.
What interventions are being tested in trial NCT07101666?
The interventions under investigation include: Short course radiation therapy (RADIATION), Standard of care neoadjuvant chemotherapy (DRUG).
Who is sponsoring clinical trial NCT07101666?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.